Medical News

RSS

BUSM researchers identify clinical characteristics associated with PDUD in primary care patients

Researchers at Boston University School of Medicine have identified clinical characteristics associated with prescription drug use disorder in primary care patients with chronic pain. The study found that by identifying characteristics of prescription drug abuse, primary care clinicians can identify those at risk and provide appropriate treatment.

15 May 2010

Omnicare extends Early Tender Deadline of tender offer for 6.75% Senior Subordinated Notes due 2013

Omnicare, Inc., announced today that is has extended the Early Tender Deadline of the tender offer and consent solicitation for its outstanding 6.75% Senior Subordinated Notes due 2013 to 5:00 p.m., New York City time, on May 18, 2010, unless further extended.

15 May 2010

SynerMed announces achievement of Elite status on 2010 SOE assessment

SynerMed, Inc., the largest Medicaid managed service organization in the country, today announced the achievement of "Elite" status on the 2010 Standards of Excellence assessment administered by the California Association of Physician Groups, the nation's largest professional association representing physicians practicing in the managed care model.

15 May 2010

Protox announces positive top-line results from the TRIUMPH study in first quarter 2010

Protox Therapeutics Inc. a leader in the development of receptor targeted fusion proteins, today released financial results for the first quarter 2010, ended March 31, 2010. "The first quarter of 2010 marked significant achievements for the company, namely the announcement of positive top-line results from the TRIUMPH study and the subsequent completion of a five million dollar financing," said Dr. Fahar Merchant, President and CEO of Protox.

15 May 2010

Miami-area resident charged in $23M HIV infusion Medicare fraud scheme

A Miami-area resident who owned and operated an HIV infusion clinic was arrested today and charged for her alleged participation in a $23 million HIV infusion Medicare fraud scheme, the Departments of Justice and Health and Human Services (HHS) announced.

15 May 2010

Biovest International announces filing of proposed Plan of Reorganization

Biovest International, Inc. today announced that the Company filed its proposed Plan of Reorganization with the U.S. Bankruptcy Court for the Middle District of Florida, Tampa Division. With this filing, Biovest is positioned to emerge from Chapter 11 protection this summer as a fully restructured company.

15 May 2010

The George Washington University Board of Trustees approve formation of GW School of Nursing

Today, The George Washington University Board of Trustees voted to approve the formation of the GW School of Nursing. The nursing school will be composed of the Master of Science in Nursing programs, the Doctor of Nursing Practice program, the second degree Bachelor of Science in nursing program, and other post-masters certificate programs.

15 May 2010

Research sheds light on early embryogenesis, genetic disease

Chromosome 22q11 deletion syndrome (also known as DiGeorge syndrome) is the most common human chromosome deletion syndrome, having an estimated incidence of at least one in 4,000 live births.

15 May 2010

U.S. Patent and Trademark Office grants patent to Historx's AQUA technology

HistoRx , Inc., announced today that the U.S. Patent and Trademark Office has granted a patent protecting the company's methods for determining a cancer patient's prognosis based on sub-cellular localization of biomarkers.

15 May 2010

Intellipharmaceutics announces dismissal of patent litigation settlement on Focalin XR drug

Intellipharmaceutics International Inc. and its wholly owned subsidiary Intellipharmaceutics Corp. today announced that it and its licensee and development partner Par Pharmaceutical, Inc. ("Par") have received confirmation that the previously announced stays of the patent litigation concerning a generic version of Novartis' Attention Deficit Hyperactivity Disorder drug, Focalin XR®, (dexmethylphenidate hydrochloride), have expired without regulatory intervention, and that the parties have stipulated to a dismissal of the litigation.

15 May 2010

US Oncology Specialty passes VAWD accreditation program

US Oncology, Inc.'s Fort Worth, Texas distribution facility, US Oncology Specialty, LP, has once again successfully passed the National Association of Boards of Pharmacy Verified-Accredited Wholesale Distributors program's comprehensive criteria review and on-site inspection.

15 May 2010

RPS first-quarter service revenues increase 28.2% to $58.0M

ReSearch Pharmaceutical Services, Inc., a leading provider of integrated clinical development outsourcing solutions to the bio-pharmaceutical industry, announces its results for the quarter ended March 31, 2010. These statements include unaudited comparative results for RPS for the quarter ended March 31, 2009.

15 May 2010

Welch Allyn honors four sales and marketing professionals with outstanding performance awards

Welch Allyn, a leading manufacturer of frontline medical products and solutions, recently honored four North American sales and marketing professionals with outstanding performance awards at its 2010 Sales Meeting in Naples, Florida.

15 May 2010

Differential diagnosis and therapy for gait disturbance

One in four people over the age of 70 suffers from gait disturbance. To prevent falls, specific treatment should be given. In the current issue of Deutsches -rzteblatt International, Klaus Jahn and colleagues describe methods of differential diagnosis and therapy (Dtsch Arztebl Int 107[17]: 306-16).

15 May 2010

New research facility at Riley Hospital for Children to improve clinical research trials for children

A new research facility at Riley Hospital for Children will dramatically improve the process of turning the results of laboratory research into new treatments for sick children, federal and local officials said Friday.

15 May 2010

IpAuctions schedules sale of Zassi's pouchless ostomy management technology IP portfolio

IpAuctions™ has scheduled a live international corporate sale of the extensive IP portfolio of pouchless ostomy management technologies owned by Zassi Holdings, Inc. Zassi, the Florida-based firm, fosters breakthrough medical devices that are materially evolving the life sciences industry.

15 May 2010

Medical News

BUSM researchers identify clinical characteristics associated with PDUD in primary care patients

Omnicare extends Early Tender Deadline of tender offer for 6.75% Senior Subordinated Notes due 2013

SynerMed announces achievement of Elite status on 2010 SOE assessment

Protox announces positive top-line results from the TRIUMPH study in first quarter 2010

Miami-area resident charged in $23M HIV infusion Medicare fraud scheme

Biovest International announces filing of proposed Plan of Reorganization

The George Washington University Board of Trustees approve formation of GW School of Nursing

Research sheds light on early embryogenesis, genetic disease

U.S. Patent and Trademark Office grants patent to Historx's AQUA technology

Intellipharmaceutics announces dismissal of patent litigation settlement on Focalin XR drug

US Oncology Specialty passes VAWD accreditation program

RPS first-quarter service revenues increase 28.2% to $58.0M

Welch Allyn honors four sales and marketing professionals with outstanding performance awards

Differential diagnosis and therapy for gait disturbance

New research facility at Riley Hospital for Children to improve clinical research trials for children

IpAuctions schedules sale of Zassi's pouchless ostomy management technology IP portfolio

CRC Health first-quarter consolidated net revenue increases 1.1% to $104.0 million

HSPH researchers succeed in locking malaria parasites within infected blood cells

Inhibitex commences trials on INX-189 for treatment of Hepatitis C infections

Registered nurses from PRHC to provide fact sheets about cuts to beds, RNs

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News